<DOC>
	<DOCNO>NCT01251237</DOCNO>
	<brief_summary>It particularly important thorough gut cleansing achieve prior colonoscopy procedure successful . Polyethylene glycol plus electrolyte ( PEG+E ) solution well establish safe effective agent gut cleanse Norgine successfully develop low volume ( 2 litre ) PEG+E gut lavage solution . The efficacy safety solution similar standard 4 litre PEG+E , improve patient acceptance . Tolerance , acceptability satisfaction cleanse agent play important role subject ' compliance gut preparation procedure . The study medication NRL0706 identical PEG+E-containing gut lavage solution commonly use clinical practice , exception flavour modify lemon orange . This study investigate tolerability , acceptability , safety efficacy single dose NRL0706 ( MOVIPREP Orange ) subject without gastrointestinal symptom undergo colonoscopy colon cancer screening .</brief_summary>
	<brief_title>Study Assess Tolerability , Safety Efficacy Adapted Gut Cleansing Solution Routine Colon Cleansing Prior Colonoscopies</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>The subject 's write informed consent must obtain prior inclusion . Male female ambulatory subject age 40 75 year undergoing complete colonoscopy colon cancer screen . No history significant gastrointestinal disease , include gastrointestinal obstruction perforation acute symptom require colonoscopy procedure . Willing undergo colonoscopy colon cancer screen . Willing , able competent complete entire procedure comply study instruction . Females childbearing potential must employ adequate method contraception . History gastric empty disorder History ileus , toxic megacolon , gastrointestinal obstruction colonic perforation History Phenylketonuria Known Glucose6phosphate dehydrogenase deficiency Known hypersensitivity macrogol 3350 , sodium sulphate ascorbic acid/ sodium ascorbate History colonic resection Requirement permanent medication associate stable serum concentration ( e.g . neuroleptic drug ) Presence congestive heart failure ( NYHA III + IV ) Acute lifethreatening cardiovascular disease Documented history severe renal insufficiency Application unlicensed medication within previous 3 month participation research study last 3 month Females pregnant , nurse planning pregnancy . Females child bear potential use reliable method contraception Subjects investigator feel would compliant requirement trial</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>